- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04283331
Anesthetic Impregnated Bandage Soft Contact Lens (BSCL) in Pain Management After Photorefractive Keratectomy (PRK)
Efficacy and Safety of Anesthetic Impregnated Bandage Soft Contact Lens (BSCL) in Pain Management After Photorefractive Keratectomy (PRK).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Photorefractive keratectomy (PRK) is a popular method for the correction of refractive errors. Compared to laser-assisted in situ keratomileusis (LASIK), PRK is often associated with more discomfort and requires more downtime. However, it is oftentimes considered the preferred method of refractive surgery for patients with dry eye syndrome, high refractive errors, thin corneas, or those with more active lifestyles who may be more prone to dislodging their LASIK flaps. It can also avoid other complications associated with LASIK including striae, folds, diffuse lamellar keratitis, and epithelial ingrowth. As a result, improved management of post-operative pain in patients undergoing PRK is critical in order encourage utilization and patient preference of this procedure.
The current standard of care for pain management after PRK is the use of a bandage soft contact lens (BSCL). BSCLs may speed reepithelialization and function as an adjunct for pain control.
Using a BSCL soaked in proparacaine has not yet been studied as a pain management method after PRK. Our hypothesis is that combining these two methods will result in greater pain reduction than using a BSCL alone, which is the current standard of care. Furthermore, soaking the BSCL in anesthetics will reduce the chance that patients can abuse anesthetic medication postoperatively, which is the concern when patients are sent home with anesthetic drops as is noted in several prior studies.
This study aims to explore the potential of an anesthetic soaked bandage soft contact lens in reducing pain levels compared to a bandage soft contact lens alone after PRK.
Study Goals:
- To assess the perception of pain following photorefractive keratectomy with the utilization of an anesthetic soaked bandage soft contact lens versus control (BSCL only) using the Visual Analog Pain Scale.
- To assess the effect of an anesthetic soaked bandage soft contact lens on re-epithelialization following photorefractive keratectomy versus control. This will be assessed on post-operative day 5 as whether there is a persistent epithelial defect or not, a binary outcome.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Beeran Meghpara, MD
- Phone Number: 2159283180
- Email: bmeghpara@willseye.org
Study Contact Backup
- Name: Cherie A Fathy, MD, MPH
- Phone Number: 2159283000
- Email: cherie.fathy@jefferson.edu
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19123
- Recruiting
- Wills Eye Hospital
-
Contact:
- Beeran Meghpara, MD
- Phone Number: 215-928-3180
- Email: bmeghpara@willseye.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All eyes approved for photorefractive keratectomy with Dr. Beeran Meghpara or Dr. Christopher Rapuano, with or without the assistance of residents.
Exclusion Criteria:
- Patients undergoing unilateral procedure.
- Eyes that experience complication during the photorefractive keratectomy procedure
- Patients who are pregnant or breast feeding
- Patients under 18 years of age
- Patients with a history of eye surgery or trauma and those with irregular astigmatism, keratoconus, or any other type of corneal disorder, pregnancy, diabetic retinopathy, or glaucoma.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bandage Contact Lens + Proparacaine
The eye that receives a bandage contact lens soaked in proparacaine.
|
Each subject will have one eye randomized to receive a bandage contact lens soaked in anesthetic solution (proparacaine hydrochloride 0.5%) and the following eye will serve as a control and receive a bandage soft contact lens soaked in balanced salt solution, which is the current standard of care for PRK.
Other Names:
|
No Intervention: Bandage Contact Lens WITHOUT Proparacaine
The eye that receives a bandage contact lens (standard of care).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daily pain score at post-operative day 0 through post-operative day 5
Time Frame: 5 days
|
Primary Outcome Measure is pain score at post-operative day 0 THROUGH post-operative day 5. Patients will be asked to fill out their score daily. The Wong-Baker Faces pain scale will be used to measure pain. This is a self-report measure of pain consisting of a series of faces with expressions of increasing distress. Each face is also given a numerical rating from 0 to 5, zero representing no pain and 5 representing worst pain. |
5 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complete re-epithelialization at post-operative day 5
Time Frame: 5 days
|
A binary outcome (yes/no) of whether the corneal epithelium has completely healed by post-operative day 5.
|
5 days
|
Final refractive outcome at postoperative month 3
Time Frame: 3 Months
|
Snellen visual acuity, both without correction and best corrected with a manifest refraction.
|
3 Months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Beeran Meghpara, MD, Wills Eye Hospital at TJUH
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-871
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Errors
-
Suzan A RattanCompletedRefractive Errors | Refractive SurgeryIraq
-
London School of Hygiene and Tropical MedicineBritish Council for Prevention of Blindness; Tanzanian Society for the BlindCompletedUnder- and Uncorrected Significant Refractive ErrorsTanzania
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Chulalongkorn UniversityNot yet recruitingRefractive Errors
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive ErrorUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Wang HongxiaTianjin Eye HospitalUnknownRefractive ErrorChina
Clinical Trials on Proparacaine Ophthalmic
-
American Genomics, LLCCompletedAnesthesia, LocalUnited States
-
Children's Hospital of PhiladelphiaTerminated
-
Louisiana State University Health Sciences Center...RecruitingEpiphora | Dacryostenosis | DacryocystitisUnited States
-
William Beaumont HospitalsTerminatedEpiphora | Dacryostenosis | DacryocystitisUnited States
-
Lin ZhongUnknownPerioperative Pain ExperiencesChina
-
Lahey ClinicCompletedMacular DegenerationUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedOcular Inflammation | Ocular Pain | Corneal Endothelial Cell Loss | Cataract SurgeryUnited States
-
Chengdu Kanghong Biotech Co., Ltd.CompletedMacular Edema | Branch Retinal Vein OcclusionChina
-
Aldeyra Therapeutics, Inc.CompletedAllergic ConjunctivitisUnited States
-
Laboratorios Sophia S.A de C.V.WithdrawnConjunctivitis, Allergic | Seasonal Allergic Conjunctivitis | Ocular Itching | Ocular Allergy | Perennial Allergic ConjunctivitisMexico